[9] Kimura A,Nakata Y,Hyodo H,et al.Platelet-derived growth factor expression in accelerated and blastic phase of chronic myelogenous leukemia with myelofibrosis.Br J Haematol,1994,86:303-307.
[10] Carapeti M,Soede BA,Hochhaus A,et al.Rarity of dominant-negative mutations of the G-CSF receptor in patients with blast crisis of chronic myeloid leukemia or de novo acute leukemia.Leukemia,1997,11:1005-1008.
[11] Tanaka K,Takauchi K,Takechi M,et al.High frequency of RAS oncogene mutation in chronic myeloid leukemia patients with myeloblastoma.Leuk Lymph,1994,13:317-322.
[12] Kubonishi I,Asahi Y,Machida H,et al.PTHrP-mediated hypercalcaemia in a case of CML blast crisis.Br J Haematol,1997,96:165-167.
[13] Gaidano G,Guerrasio A,Serra A,et al.Molecular mechanisms of tumor progression in chronic myeloproliferative disorders.leukemia,1994,8(Suppl):27-29.
[14] Handa H,Hegde UP,Kotelnikov VM,et al.Bcl-2 and c-myc expression,cell cycle kinetics and apoptosis during the progression of chronic myeloid leukemia from diagnosis to blast crisis.Leuk Res,1997,21:479-489.
[15] Mitani K.Molecular mechanism of blastic crisis in chronic myelocytic leukemia. Leukemia, 1997,3(Suppl):503-505.
[16] Fenaux P.The clinical significance of mutations of the P53 tumor suppresser gene in hematological malignancies.Br J Haematol,1997,98:502-511.
[17] Nakai H,Kaneko H,Horiike S.Multiple aberrant splicing of the P53 transcript without genomic mutations around exon-intron junctions in a case of CML in blast crisis——a possible novel mechanism of P53 inactivation.Br J Haematol,1994,87:839-842.
[18] Serra I,Gottardi E,Ragione FD,et al.Involvement of the cyclin-dependent kinase-4 inhibitor(CDNK2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukemia.Br J Haematol,1995,91:625-629.
[19] Dong WF,Heng HH,Lowsky R,et al.Cloning,expression,and chromosomal localization to 11p12-13 of a human LIM/HOMEOBOX gene,hLim-1.DNA Cell Biol,1997,16:671-678.
[20] Schimamata T,Ohyashiki K,Ohyshiki JH,et al.The expression pattern of erythrocyte/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia.Blood,1995,86:3173-3180.
[21] Mills KI,Guina BA,Walsh VA,et al.Increasing methylation of the calcitonin gene in CML patients.Leuk Res,1996,20:771-775.
[22] Kiyoi H,Fukutani H,Yamauchi T,et al.Continuing immunoglobulin heavy chain gene rearrangements in chronic myeloid leukemia with recurrent B-lymphoid blast crisis after bone marrow transplantation.Leukemia,1995,9:265-270.